Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. [electronic resource]
Producer: 19970311Description: 454-61 p. digitalISSN:- 1098-4275
- Bronchiolitis -- complications
- Bronchopulmonary Dysplasia -- complications
- Child, Preschool
- Double-Blind Method
- Follow-Up Studies
- Heart Defects, Congenital -- complications
- Hospitalization
- Humans
- Immunoglobulins, Intravenous -- therapeutic use
- Infant
- Infant, Newborn
- Infant, Premature
- Pneumonia, Viral -- complications
- Respiratory Syncytial Virus Infections -- complications
- Respiratory Syncytial Virus, Human -- immunology
- Risk Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comment; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.